vs
AlTi Global, Inc.（ALTI）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
AlTi Global, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.2倍（$86.6M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -15.1%，领先399.2%），AlTi Global, Inc.同比增速更快（87.0% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 30.6%）
该公司原名Cristal Global，是全球第二大二氧化钛生产商，同时也是钛化学品的龙头供应商，由原国家二氧化钛有限公司与 Millennium Chemicals 合并组建而成，总部设于沙特阿拉伯吉达。该公司是全球第五大二氧化钛原料生产商Bemax的重要股东。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
ALTI vs RIGL — 直观对比
营收规模更大
ALTI
是对方的1.2倍
$69.8M
营收增速更快
ALTI
高出65.8%
21.2%
净利率更高
RIGL
高出399.2%
-15.1%
两年增速更快
RIGL
近两年复合增速
30.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $86.6M | $69.8M |
| 净利润 | $-13.1M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | -2.1% | 33.2% |
| 净利率 | -15.1% | 384.0% |
| 营收同比 | 87.0% | 21.2% |
| 净利润同比 | 75.6% | 1769.2% |
| 每股收益（稀释后） | — | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALTIRIGL
| Q4 25 | $86.6M | $69.8M | ||
| Q3 25 | $57.2M | $69.5M | ||
| Q2 25 | $53.1M | $101.7M | ||
| Q1 25 | $58.0M | $53.3M | ||
| Q4 24 | $46.3M | $57.6M | ||
| Q3 24 | $51.8M | $55.3M | ||
| Q2 24 | $49.5M | $36.8M | ||
| Q1 24 | $50.8M | $29.5M |
净利润ALTIRIGL
| Q4 25 | $-13.1M | $268.1M | ||
| Q3 25 | $-84.1M | $27.9M | ||
| Q2 25 | $-24.4M | $59.6M | ||
| Q1 25 | $1.9M | $11.4M | ||
| Q4 24 | $-53.8M | $14.3M | ||
| Q3 24 | $-72.5M | $12.4M | ||
| Q2 24 | $-6.4M | $-1.0M | ||
| Q1 24 | $29.7M | $-8.2M |
毛利率ALTIRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率ALTIRIGL
| Q4 25 | -2.1% | 33.2% | ||
| Q3 25 | -49.8% | 40.9% | ||
| Q2 25 | -56.7% | 60.1% | ||
| Q1 25 | -23.3% | 23.9% | ||
| Q4 24 | -42.7% | 28.9% | ||
| Q3 24 | -18.4% | 25.4% | ||
| Q2 24 | -30.2% | 1.2% | ||
| Q1 24 | -28.9% | -23.6% |
净利率ALTIRIGL
| Q4 25 | -15.1% | 384.0% | ||
| Q3 25 | -147.0% | 40.2% | ||
| Q2 25 | -45.9% | 58.6% | ||
| Q1 25 | 3.3% | 21.5% | ||
| Q4 24 | -116.1% | 24.9% | ||
| Q3 24 | -140.0% | 22.5% | ||
| Q2 24 | -12.9% | -2.8% | ||
| Q1 24 | 58.4% | -27.9% |
每股收益（稀释后）ALTIRIGL
| Q4 25 | — | $14.11 | ||
| Q3 25 | — | $1.46 | ||
| Q2 25 | $-0.33 | $3.28 | ||
| Q1 25 | $-0.04 | $0.63 | ||
| Q4 24 | $-0.71 | $0.82 | ||
| Q3 24 | $-0.88 | $0.70 | ||
| Q2 24 | $-0.18 | $-0.06 | ||
| Q1 24 | $0.18 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $41.2M | $155.0M |
| 总债务越低越好 | $883.0K | $52.5M |
| 股东权益账面价值 | $600.1M | $391.5M |
| 总资产 | $1.2B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.00× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资ALTIRIGL
| Q4 25 | $41.2M | $155.0M | ||
| Q3 25 | $35.8M | $137.1M | ||
| Q2 25 | $42.4M | $108.4M | ||
| Q1 25 | $52.8M | $77.1M | ||
| Q4 24 | $64.4M | $77.3M | ||
| Q3 24 | $220.6M | $61.1M | ||
| Q2 24 | $60.0M | $49.1M | ||
| Q1 24 | $134.2M | $49.5M |
总债务ALTIRIGL
| Q4 25 | $883.0K | $52.5M | ||
| Q3 25 | $586.0K | $60.0M | ||
| Q2 25 | $673.0K | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | $0 | $60.0M | ||
| Q3 24 | $128.4M | $60.0M | ||
| Q2 24 | $164.0M | $60.0M | ||
| Q1 24 | $183.7M | $60.0M |
股东权益ALTIRIGL
| Q4 25 | $600.1M | $391.5M | ||
| Q3 25 | $607.2M | $117.6M | ||
| Q2 25 | $685.4M | $81.9M | ||
| Q1 25 | $665.2M | $18.6M | ||
| Q4 24 | $658.4M | $3.3M | ||
| Q3 24 | $707.0M | $-14.6M | ||
| Q2 24 | $540.2M | $-29.9M | ||
| Q1 24 | $510.9M | $-31.7M |
总资产ALTIRIGL
| Q4 25 | $1.2B | $513.6M | ||
| Q3 25 | $1.2B | $242.5M | ||
| Q2 25 | $1.2B | $206.7M | ||
| Q1 25 | $1.2B | $176.0M | ||
| Q4 24 | $1.3B | $164.0M | ||
| Q3 24 | $1.4B | $139.4M | ||
| Q2 24 | $1.3B | $128.4M | ||
| Q1 24 | $1.3B | $126.5M |
负债/权益比ALTIRIGL
| Q4 25 | 0.00× | 0.13× | ||
| Q3 25 | 0.00× | 0.51× | ||
| Q2 25 | 0.00× | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | 0.00× | 18.25× | ||
| Q3 24 | 0.18× | — | ||
| Q2 24 | 0.30× | — | ||
| Q1 24 | 0.36× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-51.4M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-52.2M | — |
| 自由现金流率自由现金流/营收 | -60.3% | — |
| 资本支出强度资本支出/营收 | 0.9% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ALTIRIGL
| Q4 25 | $-51.4M | $22.0M | ||
| Q3 25 | $-53.5M | $24.0M | ||
| Q2 25 | $-19.9M | $30.5M | ||
| Q1 25 | $-30.2M | $-893.0K | ||
| Q4 24 | $-50.7M | $14.5M | ||
| Q3 24 | $-4.9M | $21.7M | ||
| Q2 24 | $-30.2M | $302.0K | ||
| Q1 24 | $-15.5M | $-5.0M |
自由现金流ALTIRIGL
| Q4 25 | $-52.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-20.0M | — | ||
| Q1 25 | $-31.0M | — | ||
| Q4 24 | $-58.2M | — | ||
| Q3 24 | $-9.4M | — | ||
| Q2 24 | $-31.2M | — | ||
| Q1 24 | $-15.7M | — |
自由现金流率ALTIRIGL
| Q4 25 | -60.3% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -37.6% | — | ||
| Q1 25 | -53.4% | — | ||
| Q4 24 | -125.7% | — | ||
| Q3 24 | -18.2% | — | ||
| Q2 24 | -63.2% | — | ||
| Q1 24 | -30.9% | — |
资本支出强度ALTIRIGL
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 16.3% | — | ||
| Q3 24 | 8.7% | — | ||
| Q2 24 | 2.2% | — | ||
| Q1 24 | 0.4% | — |
现金转化率ALTIRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | -15.80× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.52× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALTI
| Management Advisory Fees | $51.1M | 59% |
| Other | $32.7M | 38% |
| Distributions From Investments | $2.9M | 3% |
RIGL
暂无分部数据
